CALCIUM (ARSENAZO)
Determination of calcium level in plasma, serum and urine is used for monitoring and as an aid in the diagnosis of clinical conditions associated with hypocalcemia and hypercalcemia. Increase in calcium concentration occurs in endocrine disorders such as primary hyperparathyroidism, hyperthyroidism, adrenal insufficiency and in malignant neoplasms. Low calcium level can occur in cirrhosis, nephrotic syndrome, hypoparathyroidism, hypothyroidism, in dialysis patients, and tetany. The test is used to monitor the effectiveness of calcium supplementation in patients with osteoporosis.
Specification
Method |
arsenazo III, colorimetric |
Specimen |
serum, plasma, urine |
On board stability |
up to 12 weeks |
Calibration stability |
up to 12 weeks |
Measuring range |
0,32-22 mg/dl |
Regulatory status |
CE IVD |
Reagent lines
Multipurpose Line
Liquick Cor-CALCIUM ARSENAZO 30
Liquick Cor-CALCIUM ARSENAZO 60
Liquick Cor-CALCIUM ARSENAZO 120ACCENT-200
ACCENT-300
A-400
A-800
Prestige 24i
Prestige 24i CALCIUM ARSENAZO (24 positions reagent tray)
Prestige 24i CALCIUM ARSENAZO (36 positions reagent tray)B50
OS
HC
Panels: bone metabolism, electrolytes, routine screening, oncological, pregnancy, renal
Available reagents
A-800 CALCIUM ARSENAZO
ACCENT-200 CALCIUM ARSENAZO
ACCENT-300 CALCIUM ARSENAZO
B50-CALCIUM ARSENAZO
HC-CALCIUM ARSENAZO
LIQUICK COR-CALCIUM ARSENAZO
OS-CALCIUM ARSENAZO
PRESTIGE 24i CALCIUM ARSENAZO
The specification was based on data determined on selected analyzers. We recommend that all users should refer to the instruction for use (IFU) and instruments’ user or service manuals before proceeding.
Order this product
To order this product, please contact your Area Sales Manager for details. If you have any questions, click the button below and fill out the form. We will contact you as soon as possible.